论文部分内容阅读
目的 :观察吲哒帕胺的降血压作用 ,不良反应及与卡托普利合用的临床疗效。方法 :入院原发高血压患者随机分为A组(吲哒帕胺 )和B组 (吲哒帕胺 +卡托普利 )每日测血压两次。同时观察副作用。治疗前后查血电解质 ,血糖、血脂、血尿酸。结果 :治疗后两组血压均有所下降 ,疗效接近 ,总有效率 83 3 %,脂代谢和血电解质无明显影响 ,血尿酸升高。结论 :吲哒帕胺治疗原发性高血压疗效确切 ,与卡托普利合用有较好的协同作用
Objective: To observe the antihypertensive effect of indapamide, adverse reactions and clinical efficacy with captopril. Methods: Hypertensive patients admitted to hospital were randomly divided into group A (Indapamide) and group B (Indapamide + Captopril). Blood pressure was measured twice a day. At the same time observe the side effects. Check blood electrolytes before and after treatment, blood glucose, blood lipids, blood uric acid. Results: The blood pressure of both groups decreased after treatment, the curative effect was close, the total effective rate was 83.3%, the lipid metabolism and blood electrolytes had no obvious effect, and the blood uric acid increased. Conclusions Indapamide is effective in treating essential hypertension and has a synergistic effect with captopril